ALFA Finder
18:34 IST
NSE
Dividend
Concord Biotech Dividend
Concord Biotech recommended a final dividend of ₹7.55 per equity share for FY 2025-26. The record date for payment is July 24, 2026.
Concord Biotech Ltd
- Share price
- ₹597.20
- Market cap
- ₹12,495 Cr
- Revenue (annual)
- ₹1,055 Cr
- Net profit (annual)
- ₹260.9 Cr
- P/E (TTM)
- 44.2×Sector 43.8×
- Promoter holding
- 44.09%+0.01% QoQ
- FII holding
- 7.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Earnings Call 7Bonus Issue 5Financial Results 4Board Meeting Date 4Regulatory Approval 3Other Announcement 3Business Update 2Annual General Meeting 2Management Change 1Legal & Regulatory 1Dividend 1Annual Report 1
Time
34 announcements with these filters
18:19 IST
BSE
Financial Results
Concord Biotech Q4 FY26 Results: Net Profit ₹88.5 Cr, Down 37.0% YoY
Concord Biotech Ltd reported revenue from operations of ₹326.1 Cr (-24.1% YoY) and net profit of ₹88.5 Cr (-37.0% YoY) for Q4 FY26.
- Key figure
- Net profit ₹88.5 Cr · -37.0% YoY
18:18 IST
BSE
Financial Results
Concord Biotech Financial Results
Concord Biotech approved its FY26 audited financial results and recommended a final dividend of Rs. 7.55 per share. It also appointed Mrs. Ekta Gupta as an Additional Independent Director.
10:36 IST
BSE
Board Meeting Date
Concord Biotech Board Meeting Date
Concord Biotech scheduled a board meeting on May 29, 2026, to approve annual financial results. The board will also consider recommending a final dividend.